Literature DB >> 10099745

Anaemia and perinatal outcome in Port Moresby.

G Mola1, M Permezel, A B Amoa, C A Klufio.   

Abstract

In 1987, a computerized obstetric database was set up at the Port Moresby General Hospital. Between 1987 and 1992, 27,117 births took place. The mean haemoglobin value amongst the 83% of women in whom a haemoglobin value was tested was 10.0 +/- 1.7 g/dL. High stillbirth rates (94 per 1,000) were associated with a haemoglobin value < 6 g/dL. The stillbirth rate was slightly lower (14 per 1,000) in woman whose lowest haemoglobin value was in the range 10.0-10.9 g/dL than in those with a haemoglobin value > or = 11 g/dL (18 per 1,000). The stillbirth rate was increased in women with haemoglobin values > or = 14.0 g/dL. With respect to low birth-weight (< 2,500 g), the rates were also higher when the haemoglobin value was above 14.0 g/dL. The reason for these findings is not apparent and may be due to the impact of an uncharacterized confounding variable rather than the haemoglobin value.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10099745     DOI: 10.1111/j.1479-828x.1999.tb03439.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  3 in total

1.  Intravenous iron sucrose and oral iron for the treatment of iron deficiency anaemia in pregnancy.

Authors:  G D Abhilashini; Haritha Sagili; Rani Reddi
Journal:  J Clin Diagn Res       Date:  2014-05-15

Review 2.  Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis.

Authors:  Batool A Haider; Ibironke Olofin; Molin Wang; Donna Spiegelman; Majid Ezzati; Wafaie W Fawzi
Journal:  BMJ       Date:  2013-06-21

Review 3.  Maternal hemoglobin concentrations across pregnancy and maternal and child health: a systematic review and meta-analysis.

Authors:  Melissa F Young; Brietta M Oaks; Sonia Tandon; Reynaldo Martorell; Kathryn G Dewey; Amanda S Wendt
Journal:  Ann N Y Acad Sci       Date:  2019-04-17       Impact factor: 5.691

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.